78.4% of males survive non-Hodgkin lymphoma for at least one year. This falls to 63.7% surviving for five years or more, as shown by age-standardised net survival for patients diagnosed with non-Hodgkin lymphoma during 2013-2017 in England. Survival for females at one year is 80.6% and falls to 68.1% surviving for at least five years. Survival for females is higher than for than for males at one year, and higher than for males at five years.
Non-Hodgkin Lymphoma (C82-C85), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England, 2013-2017
Non-Hodgkin lymphoma survival continues to fall beyond five years after diagnosis. 51.8% of males and 58.1% of females are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with non-Hodgkin lymphoma during 2013-2017 in England.
Office for National Statistics, Cancer survival by stage at diagnosis for England, 2019.
About this data
Data is for: England, 2013 - 2017, ICD-10 C82 to C85.
Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.